Ameritas Investment Partners’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $70.6K | Hold |
|
|||||
|
2025
Q2 | $69.2K | Hold |
|
|||||
|
2025
Q1 | $67.9K | Hold |
|
|||||
|
2024
Q4 | $77.6K | Hold |
|
|||||
|
2024
Q3 | $88.1K | Hold |
|
|||||
|
2024
Q2 | $80.6K | Buy |
|
|||||
|
2024
Q1 | $33.9K | Hold |
|
|||||
|
2023
Q4 | $26.7K | Hold |
|
|||||
|
2023
Q3 | $26.3K | Hold |
|
|||||
|
2023
Q2 | $39.4K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $4K | Hold |
|
|||||
|
2020
Q4 | $10K | Hold |
|
|||||
|
2020
Q3 | $9K | Hold |
|
|||||
|
2020
Q2 | $12K | Buy |
|